Peter Luther

Peter is a senior executive with 30 years of proven leadership and a strong track record of delivering results. He has a diverse background in consumer-packaged goods, medical devices & diagnostics and OTC drugs operating in stable and turnaround situations with global experience in both large company and smaller PE backed company environments. Peter is currently serving as Chairman of Vytalogy Wellness and the U.S. Soccer Foundation. In addition, he is a Director of CeQur and a private equity strategic advisor. Prior to these roles, Peter was President and Chief Executive Officer of Atrium Innovations, a globally-recognized leader in the development, manufacturing, and commercialization of nutritional supplements. Peter joined Atrium when the company was taken private by Permira in 2014 and led it through its successful acquisition by Nestlé for $2.3B, a 4.3x return, in March of 2018. Prior to Atrium, Peter was with Johnson & Johnson for 25 years where he served as President of several of the company’s large divisions over his last 10+ years including J&J Consumer Healthcare, J&J Beauty Care, J&J OTC and LifeScan. During his tenure, Peter had the opportunity to run some of the world’s most iconic brands, including Neutrogena®, Aveeno®, Listerine®, Band-Aid®, Neosporin®, Tylenol®, Zyrtec®, OneTouch® and Splenda® among others. Peter Luther has a BA in Economics from Kenyon College and an MBA from the Kellogg School of Management at Northwestern University. Peter serves on the Parents Council at Tulane University and is a past member of the Board of Visitors at the School of Business at Wake Forest and the Parents Council of Muhlenberg College. For more information, visit me at www.newsettlementpartners.com